The impact of icodextrin on the outcomes of incident peritoneal dialysis patients
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0297688 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von I-Kuan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Divisions of Nephrology, China Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Kidney Failure, Chronic, Peritonitis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Medical University Hospital.
Abstract (Originalsprache)
Objective
The aim of the study is to investigate the effects of icodextrin on the risks of death, technique failure and the first episode of peritonitis in peritoneal dialysis (PD) patients.
Methods
From medical records of a medical center in Taiwan, a total of 725 newly diagnosed end-stage kidney disease patients receiving PD for at least 90 days from January 1, 2007 to December 31, 2018 were identified. These patients were grouped as 190 icodextrin users and 535 non-users. Users were defined as utilization of icodextrin for ≥ 50% of their PD duration. The use of icodextrin was considered a time-varying exposure in the Cox proportional hazard model. The risks of death, technique failure and the first episode of peritonitis were compared between two cohorts by the end of 2018.
Results
Compared to the non-users, the icodextrin users had significant lower risks of mortality (6.5 vs.7.2 per 100 person-years; adjusted HR = 0.62, 95% CI = 0.42–0.91) and technique failure (12.7 vs. 15.2 per 100 person-years; adjusted HR = 0.61, 95% CI = 0.47–0.81), and the first peritonitis episode (5.0 vs. 17.0 per 100 person-years; adjusted HR = 0.22, 95% CI = 0.14–0.35). The risk of peritonitis reduced further in icodextrin users with diabetes and with cardiovascular disease.
Conclusion
Icodextrin was associated with lower risks of mortality, technique failure, and the first episode of peritonitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Divisions of Nephrology, China Medical University Hospital, Taichung, Taiwan.
- Department of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.
- Baxter Healthcare Ltd., Taipei, Taiwan.
- Graduate Institute of Management, National Taiwan University of Science and Technology, Taipei, Taiwan.
- Raising Statistics Consultant Inc, Taipei, Taiwan.
- Division of Nephrology, Taichung Veterans General Hospital, Taichung, Taiwan.
ORCID-Profile: I-Kuan Wang, Fung-Chang Sung
Förderung
- China Medical University Hospital
Zitieren
APA
Wang, I. K., Chan, C. I., Lin, A. H., Yu, T. M., Yen, T. H., Lai, P. C., Li, C. Y., & Sung, F. C. (2024). The impact of icodextrin on the outcomes of incident peritoneal dialysis patients. PLOS ONE. https://doi.org/10.1371/journal.pone.0297688
Vancouver
Wang IK, Chan CI, Lin AH, Yu TM, Yen TH, Lai PC, et al. The impact of icodextrin on the outcomes of incident peritoneal dialysis patients. PLOS ONE. 2024. doi:10.1371/journal.pone.0297688
BibTeX
@article{Wang2024,
author = {Wang, I-Kuan and Chan, Chan Ip and Lin, Alfred Hsing-Fen and Yu, Tung-Min and Yen, Tzung-Hai and Lai, Ping-Chin and Li, Chi-Yuan and Sung, Fung-Chang},
title = {The impact of icodextrin on the outcomes of incident peritoneal dialysis patients},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0297688}
}
EUVIMED